Dr. R. Todd Lancaster Completes Cutting Edge Procedure at The Vascular Care Group, Newton-Wellesley

Newton MA

05 May, 2022

10:55 AM

Description

The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is proud to announce that R. Todd Lancaster M.D., M.P.H. successfully completed a groundbreaking percutaneous femoral-popliteal artery bypass at the Newton-Wellesley, Mass. location. The success of this cutting-edge, minimally invasive procedure marks another step toward TVCG’s mission to providing advanced vascular interventions outside of the traditional hospital setting and expanding the possibilities of outpatient vascular care. The procedure was part of TVCG’s ongoing participation in an investigational device exemption (IDE) trial DETOUR2 Continued Access (NCT04625660) investigational device exemption (IDE) trial, sponsored by Endologix LLC. “I am proud to continue to bring the latest techniques and most advanced level of care to the Wellesley area,” said Dr. Lancaster. “With minimally invasive procedures in the outpatient setting, we can evolve the treatment of limb threatening diseases, avoid prolonged hospitalizations and even discharge patients within a few hours of completing the procedure. I am proud to participate in this trial and contribute to the advancement of cutting edge, community-based therapy.” The procedure was performed in conjunction with Vascular Breakthroughs, a clinical trials management platform. The percutaneous bypass graft is used to restore blood flow to the lower leg and foot using a minimally invasive technique that avoids hospitalization and long recovery. The PQ Bypass System was designated as a U.S. Food and Drug Administration (FDA) Breakthrough Device in 2020. Dr. Lancaster is TVCG’s second vascular surgeon to participate in the DETOUR2 clinical trials, following Stephen J. Hoenig M.D.’s successful completion of the procedure in the Leominster outpatient center in January. The patients were able to return home in only a few hours. This procedure, and similar innovative techniques performed in TVCG’s centers, enable patients to receive safe and efficient care on a local level, without requiring a trip to a major city, or a long hospital stay. The PQ Bypass System is limited by federal law to investigational use only and is not available for sale. About The Vascular Care Group   The Vascular Care Group (TVCG) is a growing group practice committed to the prevention, diagnosis, and treatment of vascular disease. The practice brings together decades of expertise among a team of vascular specialists offering unparalleled care in Massachusetts at four full-service vascular care centers with five satellite offices, from Worcester to Cape Cod. Their comprehensive services cover a broad range of conditions from non-invasive vascular testing to complex vascular surgeries, including a full spectrum of open and endovascular procedures performed in-office and at affiliated hospitals throughout the state. The care center has united some of the area’s leading vascular experts with a focus on superior patient care. More information about the practice can be found at https://vascularcaregrp.com/.   About Vascular Breakthroughs  Vascular Breakthroughs was founded by Paul J. Gagne MD, FACS, RVT in 2012 to provide a research infrastructure for physicians not affiliated with an academic institution. The organization has put new technologies in the hands of physicians working in the community, thereby improving access to novel treatments for patients and expanding the reach of cutting-edge research. Vascular Breakthroughs provides administrative support for all aspects of the implementation of a clinical trial, including recruitment, all phases in the initiation of a new trial and in the execution of a trial. More information about Vascular Breakthroughs can be found at https://vascularbreakthroughs.com/.